SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis

Clinical trial NCT02734810 · COMPLETED

Trial details

NCT number: NCT02734810
Sponsor: Anthera Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Exocrine Pancreatic Insufficiency Cystic Fibrosis

Start date: 2016-06-01
Primary completion: 2016-12-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.